Cargando…

Identification of COL1A1 associated with immune infiltration in brain lower grade glioma

Brain low grade gliomas (LGG) often give serious clinical symptoms due to the invasion towards nervous system, affecting the life quality of patients. Collagen type I alpha 1(COL1A1) is the main component of type I collagen. Although there are many reports about abnormal expression of COL1A1 in vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Junyu, Da, Junlong, Hu, Narisu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255759/ https://www.ncbi.nlm.nih.gov/pubmed/35789341 http://dx.doi.org/10.1371/journal.pone.0269533

Ejemplares similares

Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
por: Li, Xiao-min, et al.
Publicado: (2023)

Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma
por: Wu, Hongrong, et al.
Publicado: (2022)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
por: Kang, Kai, et al.
Publicado: (2021)

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
por: Ren, Xiaoyue, et al.
Publicado: (2023)

YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma
por: Lin, Xiangan, et al.
Publicado: (2020)

CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma
por: Shi, Huadi, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
por: Ji, Qiankun, et al.
Publicado: (2022)

Aberrant expression of RSK1 characterizes high‐grade gliomas with immune infiltration
por: M. Hajj, Glaucia N., et al.
Publicado: (2019)

Niobium carbide–mediated photothermal therapy for infected wound treatment
por: Ren, Junyu, et al.
Publicado: (2022)

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study
por: Hao, Zhaonian, et al.
Publicado: (2019)

PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma
por: Noor, Humaira, et al.
Publicado: (2021)

Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma
por: Zhang, Xia, et al.
Publicado: (2023)

Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma
por: Tan, Zilong, et al.
Publicado: (2022)

Integrated analysis identified CAPG as a prognosis factor correlated with immune infiltrates in lower‐grade glioma
por: Wei, Jinrui, et al.
Publicado: (2020)

High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma
por: Zhou, Min, et al.
Publicado: (2022)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
por: Lu, Jiacheng, et al.
Publicado: (2019)

Identification of Autophagy-Related Prognostic Signature and Analysis of Immune Cell Infiltration in Low-Grade Gliomas
por: Quan, Qingli, et al.
Publicado: (2021)

Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM)
por: Bai, Kun-Hao, et al.
Publicado: (2022)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021)

COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer
por: Geng, Qishun, et al.
Publicado: (2021)

COL1A1 Is a Potential Prognostic Biomarker and Correlated with Immune Infiltration in Mesothelioma
por: Zhang, Cangang, et al.
Publicado: (2021)

EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
por: Hao, Yong-Ping, et al.
Publicado: (2021)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
por: Wen, Jing, et al.
Publicado: (2020)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment
por: Zhu, Hua, et al.
Publicado: (2021)

Identification of molecular subtypes based on inflammatory response in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2022)

Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma
por: Wang, Guiyuan, et al.
Publicado: (2022)

NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis
por: Ju, Qiang, et al.
Publicado: (2020)

Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma
por: Luan, Yuxuan, et al.
Publicado: (2023)

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
por: Yu, Hai, et al.
Publicado: (2021)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
por: Hu, Zhicheng, et al.
Publicado: (2021)

Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy
por: Yang, Youyuan, et al.
Publicado: (2022)

Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification
por: Aili, Yirizhati, et al.
Publicado: (2022)

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
por: Wang, Zhi-liang, et al.
Publicado: (2022)

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Modulation of transcriptional activity in brain lower grade glioma by alternative splicing
por: Li, Jin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b1b45uvfjri6155r42mch9n0cm